WHO approval of Sinopharm vaccine set to benefit world coronavirus fight

The World Health Organization's approval to give emergency use to the COVID-19 vaccine manufactured by China's Sinopharm has been welcomed by experts and health regulators worldwide.

On Friday, the WHO gave the vaccine the green light, paving the way for potentially millions of doses to be rolled out globally to reach countries in need and boost WHO-backed efforts such as the COVAX initiative.

COVAX is a global effort aimed at ensuring access in poorer nations to novel coronavirus vaccines.